Modulation of 9-nitrocamptothecin-induced apoptosis by hyperthermia in human leukemia HL-60 cells

Anti-Cancer Drugs

Volumn 10, Issue 3, 1999, Pages 317-322

  Pantazis, Panayotis ^a,b   Chatterjee, Devasis ^a   Han, Zhiyong ^a   Wyche, James ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

9 nitrocamptothecin; Hyperthermia; Leukemia cells; Thermochemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; RUBITECAN;

APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERTHERMIA; LEUKEMIA CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CAMPTOTHECIN; FLOW CYTOMETRY; HL-60 CELLS; HUMANS; HYPERTHERMIA, INDUCED; LEUKEMIA;

EID: 0032772857     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199903000-00011     Document Type: Article

References (42)

1. Giovanella BC, Stehlin JS, Yim SO. Correlation of the thermosensitivity of cells to their malignant potential. Ann NY Acad Sci 1980; 335: 206-14.
2. Gerner EW, Cetas TC, eds. Hyperthermic oncology 1992, vol. 2, Proc 6th Int Congr Hyperthermic Oncology, Tucson, AZ 1993.
3. Allan DJ, Harmon BV. The morphological characterization of cell death induced by mild hyperthermia and comparison with death induced by ionizing radiation and cytotoxic drugs. Scanning Electron Microsc 1986; 3: 1121-33.
4. Dyson JED, Simmons DM, Daniel J, McLaughlin JM, Quirke P, Bird CC. Kinetic and physical studies of cell death induced by chemotherapeutic agents or hyperthermia. Cell Tissue Kinet 1986; 19: 311-24.
5. Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 1990; 15: 2353-62.
6. Harmon BV, Takano YS, Winterford CM, Gobe GC. The role of apoptosis in the response of cells and tumours to mild hyperthermia. Int J Radiat Biol 1991; 59: 489-501.
7. Mosser DD, Martin LH. Induced thermotolerance to apoptosis in a human T-lymphocyte cell line. J Cell Physiol 1992; 151: 561-70.
8. Agastinelli E, Arancia C, Calcabrini A, Mafarrese P, Mondovi B, Pietrangeli P. Hyperthermia-induced biochemical and ultrastructural modifications in cultured cells. Exp Oncol 1996; 17: 269-76.
9. Sellins KS, Kohen JJ. Hyperthermia induces apoptosis in thymocytes. Radiat Res 1991; 126: 88-95.
10. Harmon BV, Corder AM, Collins RJ, et al. Cell death induced in a murine mastocytoma by 42-47°C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat load. Intl J Radiat Biol 1990; 58: 845-58.
11. Pantazis P. The water-insoluble camptothecin analogues: promising drugs for the effective treatment of haematological malignancies. Leuk Res 1995; 19: 775-8.
12. Pantazis P. Preclinical studies of water-insoluble camptothecin congeners: cytotoxicity, development of resistance, and combination treatments. Clin Cancer Res 1995; 1: 1235-44.
13. Chatterjee D, Wyche J, Pantazis P. Induction of apoptosis in malignant and camptothecin-resistant human cells. Ann NY Acad Sci 1996; 803: 143-56.
14. Verschraegen CF, Natelson EA, Giovanella BC, et al. A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor. Anti-Cancer Drugs 1998; 1: 36-44.
15. Moulton S, Pantazis P, Epstein JS, Sadaie MR. 9-Nitrocamptothecin inhibits tumor necrosis factor-mediated activation of human immunodeficiency virus type 1 and enhances apoptosis in a latently infected T cell clone. AIDS Res Human Retroviruses 1998; 14: 39-49.
16. Srinivasan JM, Fajardo LF, Hahn GH. Mechanism of antitumor activity of tumor necrosis factor χ with hyperthermia in a tumor necrosis factor χ resistant tumor. J Natl Cancer Inst 1990; 82: 1904-10.
17. Wiedemann GJ, Siemens HG, Mentzel M, et al. Effects of temperature on the therapeutic efficacy and pharmacokinetics of ifosfamide. Cancer Res 1993; 53: 4268-72.
18. Sakaguchi Y, Makino M, Kaneko T, et al. Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats. Cancer Res 1994; 54: 2223-7.
19. Takeuchi H, Baba H, Inutsuku S, Maehara Y, Sugimashi K. Potentiation of the cytotoxicity of carboquone by flavone acetic acid combined with hyperthermia. Anticancer Res 1997; 8: 778-83.
20. Robins HI, D'Oleire F, Grosen E, Spriggs D. Rationale and clinical status of 41.8 degrees C systemic hyperthermia, tumor necrosis factor, and melphalan for neoplastic disease. Anticancer Res 1997; 17: 2891-4.
21. Shchepotin IB, Soldatenkov V, Wroblewski JT, et al. Apoptosis induced by hyperthermia and verapamil in vitro in a human colon cancer cell line. Int J Hyperthermia 1997; 13: 547-57.
22. Buell JF, Reed E, Lee KB, et al. Synergistic effect and possible mechanisms of tumor necrosis factor and cisplatin toxicity under moderate hyperthermia against gastric cancer cells. Ann Surg Oncol 1997; 4: 141-8.
23. Raaphorst GP, Miao J, Stewar D, Ng CE. Interactions of mild hyperthermia, cisplatin and split close irradiation in human ovarian carcinoma cells. Cancer Chemother Pharmacol 1998; 41: 491-6.
24. Teicher BA, Holden SA, Khandakar V, Herman TS. Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diaminedichloro-platinum(II)/heat/radiation] in a murine tumor. J Cancer Res Clin Oncol 1993; 119: 645-51.
25. Ng CE, Bussey AM, Raaphorst GP. Sequence of treatment is important in the modification of camptothecin induced cell killing by hyperthermia. Int J Hyperthermia 1996; 12: 663-78.
26. Kondo T, Ueda K, Kano, E. Combined effects of hyperthermia and CPT-11 on DNA strand breaks in mouse mammary carcinoma FM3A cells. Anticancer Res 1995; 5: 83-6.
27. Collins SJ, Gallo RC, Gallagher RE. Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature 1977; 270: 347-9.
28. Wani MC, Nicholas AW, Wall ME. Plant antitumor agents 23. Synthesis and antileukemia activity of camptothecin analogs. J Med Chem 1986; 29: 2358-63.
29. Pantazis P, Early JA, Mendoza JT, DeJesus AR, Giovanella BC. Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro. Cancer Res 1994; 54: 771-6.
30. Darzynkiewicz Z, Bruno S, Del Bino G, et al. Features of apoptotic cells by flow cytometry. Cytometry 1992; 13: 795-808.
31. Telford WG, King LE, Fraker PJ. Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Methods 1994; 172: 1-16.
32. Riley RS, Ross W, Mahin EJ: Miscellaneous applications of flow cytometry. In: Riley RS, Mahin EJ, Ross W, eds. Clinical applications of flow cytometry. New York: Igaku-Shoin Medical Publishers 1993: 753-807.
33. Zamai L, Falcieri E, Marhefka G, Vitale M. Supravital exposure to propidium iodide identifies apoptotic cells in the absence of nucleosomal DNA fragmentation. Cytometry 1996; 23: 303-11.
34. Pantazis P, DeJesus A, Early J, et al. Development of human leukemia U-937 cell sublines resistant to doxorubicin: induction of differentiation and altered sensitivities to topoisomerase-directed drugs. Anticancer Res 1995; 5: 1873-82.
35. Li X, Traganos F, Darzynkiewicz Z. Simultaneous analysis of DNA replication and apoptosis during treatment of HL-60 cells with camptothecin and hyperthermia and mitogen stimulation of human lymphocytes. Cancer Res 1994; 15: 4289-93.
36. Kaufman SH. Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in human leukemia cell line. Cancer Res 1991; 51: 1129-36.
37. Del Bino G, Lassota P, Darzynkiewicz Z. The S-phase cytotoxicity of camptothecin. Exp Cell Res 1991; 193: 27-35.
38. Meikranz W, Schleger R. Apoptosis and the cell cycle. J Cell Biochem 1995; 58: 160-74.
39. Yoshida A, Ueda T, Wano Y, Nakamura T. DNA damage and cell killing by camptothecin and its derivatives in human leukemia HL-60 cells. Jpn J Cancer Res 1993; 4: 566-73.
40. Inalsa M, Mitsuhashi J, Kawada S, Nakamo H. Different modes of cell-killing action between DNA topoisomerase I and II inhibitors revealed by kinetic analysis. Jpn J Cancer Res 1994; 85: 187-93.
41. Valenzuela MH, Nunez MI, Villalobos M, et al. A comparison of p53 and p16 expression in human tumor cells treated with hyperthermia or ionizing radiation. Int J Cancer 1997; 72: 307-12.
42. Matsuo K-I, Kohno K, Sato S, et al. Enhanced expression of the DNA topoisomerase I gene in response to heat shock stress in human epidermoid cancer KB cells. Cancer Res 1993; 53: 1085-90.